{"id":"https://openalex.org/W2556879866","doi":"https://doi.org/10.1182/blood.v126.23.2419.2419","title":"Targeting Replicative Stress to Treat Hematological Disorders","display_name":"Targeting Replicative Stress to Treat Hematological Disorders","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2556879866","doi":"https://doi.org/10.1182/blood.v126.23.2419.2419","mag":"2556879866"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.2419.2419","doi":"https://doi.org/10.1182/blood.v126.23.2419.2419","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2419.2419","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034020009","display_name":"Francesca Cottini","orcid":"https://orcid.org/0000-0001-8676-7840","observed_orcids":["https://orcid.org/0000-0001-8676-7840"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]},{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francesca Cottini","raw_affiliation_strings":["Internal Medicine department, Ohio State University, Columbus, OH","Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine department, Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]},{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050323670","display_name":"Giovanni Tonon","orcid":"https://orcid.org/0000-0003-2973-5038","observed_orcids":["https://orcid.org/0000-0003-2973-5038"]},"institutions":[{"id":"https://openalex.org/I4210133214","display_name":"IRCCS Ospedale San Raffaele","ror":"https://ror.org/039zxt351","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210133214","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Giovanni Tonon","raw_affiliation_strings":["Ospedale San Raffaele, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ospedale San Raffaele, Milan, Italy","institution_ids":["https://openalex.org/I4210133214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematologic Malignancy, Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C Anderson","raw_affiliation_strings":["The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5050323670"],"corresponding_institution_ids":["https://openalex.org/I4210133214"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.20594008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"2419","last_page":"2419"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.4821999967098236,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.4821999967098236,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.46070000529289246,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/replicative-stress","display_name":"replicative stress","score":0.968999981880188},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8880000114440918},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.878000020980835},{"id":"https://openalex.org/keywords/atr-inhibition","display_name":"ATR inhibition","score":0.7369999885559082},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8560000061988831},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.906000018119812},{"id":"https://openalex.org/keywords/atr-chk1-pathway","display_name":"ATR-Chk1 pathway","score":0.9010000228881836},{"id":"https://openalex.org/keywords/chromosomal-instability","display_name":"chromosomal instability","score":0.8930000066757202},{"id":"https://openalex.org/keywords/prognostic-gene-signature","display_name":"prognostic gene signature","score":0.8629999756813049},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.7369999885559082},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.7139999866485596},{"id":"https://openalex.org/keywords/replication-stress","display_name":"replication stress","score":0.4429999887943268},{"id":"https://openalex.org/keywords/dna-repair","display_name":"DNA repair","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.6170340776443481},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5899267792701721},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5395803451538086},{"id":"https://openalex.org/C178169997","wikidata":"https://www.wikidata.org/wiki/Q2892636","display_name":"Genome instability","level":4,"score":0.5140560865402222},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.5118655562400818},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4850022494792938},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.4383730888366699},{"id":"https://openalex.org/C2779733811","wikidata":"https://www.wikidata.org/wiki/Q5531562","display_name":"Gene signature","level":4,"score":0.4363107681274414},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.43088504672050476},{"id":"https://openalex.org/C2779176958","wikidata":"https://www.wikidata.org/wiki/Q18028939","display_name":"MCL1","level":4,"score":0.4288649260997772},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4035280644893646},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3785376250743866},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2881874740123749},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.27342450618743896},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.2579016089439392},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.1299518346786499}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.2419.2419","doi":"https://doi.org/10.1182/blood.v126.23.2419.2419","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.2419.2419","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2578030596","https://openalex.org/W1782106562","https://openalex.org/W2110579764","https://openalex.org/W4200013017","https://openalex.org/W2616779595","https://openalex.org/W2944281167","https://openalex.org/W2987391075","https://openalex.org/W879951825","https://openalex.org/W4389248086","https://openalex.org/W4385948980"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Combinations":[2],"of":[3,25,46,67,101,132,160,174,180,220,249,261,293,302,343,350,357,373,393,403,420,443,448,458,469,489,512,544,572,582,594,606,620,634],"chromosomal":[4,152],"translocations,":[5],"copy-number":[6],"variations,":[7],"somatic":[8],"mutations,":[9],"and":[10,50,70,75,88,111,125,127,139,154,188,217,383,385,401,423,472],"clonal":[11],"heterogeneity":[12],"that":[13,40,184,247,280,317],"characterize":[14,64],"hematological":[15,82,241,253,521],"cancers":[16],"make":[17],"every":[18],"patient":[19],"unique":[20],"from":[21,210],"a":[22,30,86,99,145,158,172,197,203,228,275,328,396,412,417,479],"genetic":[23],"point":[24],"view.":[26],"This":[27],"variety":[28],"creates":[29],"true":[31],"challenge":[32],"for":[33,150,290,353,482],"tailored":[34],"therapy.":[35],"We":[36,97,142,336,360],"have":[37,118],"previously":[38],"described":[39],"myeloma":[41],"(MM)":[42],"cells":[43,295,352,422,471],"present":[44,129,190,256,439],"signs":[45,131],"ongoing":[47,120,238],"DNA":[48,54,68,121,155,459,463,517,564],"damage,":[49,122],"activate":[51,123],"an":[52,192,579,591,603,617,631],"ATM/ABL1-dependent":[53],"damage":[55,69,156,460,565],"response":[56],"(DDR)":[57],"without":[58],"overt":[59],"apoptosis.":[60,404],"Here":[61],"we":[62,76,170],"further":[63],"the":[65,218,265,291,300,323,341,348,351,355,366,371,387],"mechanisms":[66],"replicative":[71,133,315,344],"stress":[72,316,345,437],"in":[73,157,202,239,274,296,299,370,377,386,398,440,520,566],"MM,":[74],"extend":[77],"this":[78,186,206],"knowledge":[79],"to":[80,84,92,196,264,270,279,339,429,486],"other":[81,211,240,252],"malignancies":[83,254],"evaluate":[85],"novel":[87,230],"possibly":[89],"shared":[90],"approach":[91],"synthetic":[93],"lethality":[94],"(1).":[95],"Results:":[96],"studied":[98],"panel":[100,419],"MM":[102,161,183,379,421,449],"cell":[103,113,116,380,389,425],"lines":[104,117,381,426],"together":[105],"with":[106,130,165,182,191,251,257,282,313,327,445,461,491],"acute":[107],"myeloid,":[108],"lymphoid":[109],"leukemia":[110,424],"lymphoma":[112],"lines.":[114],"Several":[115],"demonstrable":[119],"ATR":[124,363,394,414],"CHK1":[126],"also":[128,189,255],"stress,":[134],"such":[135],"as":[136],"53BP1,":[137],"RPA":[138],"RAD51":[140],"foci.":[141],"next":[143],"evaluated":[144],"gene":[146],"expression":[147,260],"signature":[148,187,207,232,267],"specific":[149,413],"increased":[151],"instability":[153,266],"cohort":[159],"patients,":[162,175],"comparing":[163],"them":[164],"normal":[166,271,475],"plasma":[167],"cells.":[168],"Specifically,":[169],"identified":[171],"subset":[173],"representing":[176,227],"around":[177],"20":[178],"percent":[179],"individuals":[181],"show":[185,246],"unfavorable":[193,494],"prognosis":[194],"due":[195],"more":[198],"aggressive":[199,446,567],"disease.":[200],"Interestingly,":[201],"multivariate":[204],"analysis,":[205],"was":[208,408,427],"independent":[209],"poor":[212],"prognostic":[213,231],"criteria,":[214],"including":[215],"proliferation":[216],"presence":[219,301],"MMSET/FGFR3":[221],"or":[222,450,584,596,608,622,636],"MAF":[223],"translocations":[224],"(2),":[225],"hence":[226],"potential":[229,483],"(3).":[233],"Gene-set":[234],"enrichment":[235],"studies":[236],"are":[237],"disorders.":[242],"However,":[243],"preliminary":[244],"data":[245],"subsets":[248],"patients":[250,444,490],"intense":[258,314],"over":[259],"genes":[262],"belonging":[263],"when":[268],"compared":[269],"B":[272],"cells,":[273],"very":[276,493],"similar":[277,406],"fashion":[278],"seen":[281],"MM.":[283],"An":[284],"intact":[285],"ATR/CHK1":[286],"pathway":[287],"is":[288,438],"crucial":[289],"survival":[292],"tumor":[294],"vivo,":[297],"especially":[298],"activated":[303],"oncogenes.":[304],"For":[305],"instance,":[306],"Em-myc":[307,324],"transgenic":[308,325],"mice":[309,326],"develop":[310],"B-cell":[311],"lymphomas":[312],"can":[318,465],"be":[319],"blocked":[320],"by":[321],"crossing":[322],"hypomorphic":[329],"Atr":[330,334],"mouse":[331],"strain":[332],"(Atr-Seckel;":[333],"S/S).":[335],"therefore":[337],"decided":[338],"exploit":[340],"concept":[342],"overload,":[346],"impeding":[347],"capacity":[349],"repairing":[354],"excess":[356],"damaged":[358],"DNA.":[359],"then":[361],"silenced":[362],"using":[364,410],"shRNAs,":[365],"upstream":[367],"protein":[368],"involved":[369],"control":[372],"stalled":[374],"replication":[375],"origins,":[376],"two":[378],"(H929":[382],"OPM-2)":[384],"Jurkat":[388],"line.":[390],"Critically,":[391],"inhibition":[392],"caused":[395],"reduction":[397],"cellular":[399],"growth":[400,432],"induction":[402],"A":[405],"phenotype":[407],"observed":[409],"VE-821,":[411],"inhibitor.":[415],"Finally,":[416],"broad":[418],"used":[428],"confirm":[430],"these":[431],"inhibitory":[433],"effects.":[434],"Conclusion:":[435],"Replicative":[436],"multiple":[441,545],"groups":[442],"types":[447],"leukemia.":[451],"Strategies":[452],"which":[453],"couple":[454],"pre-existing":[455],"high":[456],"rates":[457],"reduced":[462],"repair":[464],"specifically":[466],"cause":[467],"apoptosis":[468,519],"malignant":[470],"encouragingly":[473],"spare":[474],"ones,":[476],"thus":[477],"providing":[478],"strong":[480],"rationale":[481],"clinical":[484],"benefit":[485],"those":[487],"cohorts":[488],"otherwise":[492],"outcomes.":[495],"(1)":[496],"Cottini":[497,550],"F,":[498,528,551],"Hideshima":[499],"T,":[500],"Xu":[501],"C,":[502],"Sattler":[503],"M,":[504,506],"Dori":[505],"Agnelli":[507],"L,":[508],"et":[509,539,558],"al.":[510,540,559],"Rescue":[511],"Hippo":[513],"coactivator":[514],"YAP1":[515],"triggers":[516],"damage-induced":[518],"cancers.":[522],"Nature":[523],"medicine.":[524],"2014;20(6):599-606.":[525],"(2)":[526],"Zhan":[527],"Huang":[529],"Y,":[530],"Colla":[531],"S,":[532,538],"Stewart":[533],"JP,":[534],"Hanamura":[535],"I,":[536],"Gupta":[537],"The":[541],"molecular":[542],"classification":[543],"myeloma.":[546,568],"Blood.":[547],"2006;108(6):2020-8.":[548],"(3)":[549],"Teru":[552],"Hideshima,":[553],"Rikio":[554],"Suzuki,":[555],"Yu-Tzu":[556],"Tai,":[557],"Synthetic":[560],"lethal":[561],"approaches":[562],"exploiting":[563],"Cancer":[569],"Discovery":[570],"ahead":[571],"print.":[573],"Disclosures":[574],"Richardson:":[575],"Novartis:":[576],"Membership":[577,589,601,615,629],"on":[578,590,602,616,630],"entity's":[580,592,604,618,632],"Board":[581,593,605,619,633],"Directors":[583,595,607,621,635],"advisory":[585,597,609,623,637],"committees;":[586,598],"Millennium":[587],"Takeda:":[588],"Jazz":[599],"Pharmaceuticals:":[600],"committees,":[610,624],"Research":[611,625],"Funding;":[612,626],"Gentium":[613],"S.p.A.:":[614],"Celgene":[627],"Corporation:":[628,640],"committees.":[638],"Anderson:Celgene":[639],"Consultancy;":[641,650,652],"Oncocorp:":[642],"Equity":[643,647],"Ownership;":[644,648],"acetylon":[645],"pharmaceuticals:":[646],"Gilead:":[649],"BMS:":[651],"Millennium:":[653],"Consultancy.":[654]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-11-30T00:00:00"}